Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Effik is a pharmaceutical company specializing in women's health, with a core focus on fertility, contraception, and menopause. Founded in 1992 and headquartered in France, the company was acquired by the Italfarmaco Group in 2005, which facilitated its expansion across Europe. The Effik Fertilité brand encompasses a range of products designed to support reproductive health, including the widely recognized Inofolic and Gynositol for managing polycystic ovary syndrome (PCOS). In addition to fertility treatments, Effik provides prenatal vitamins under the Gestarelle brand and various hormonal therapies. The company is dedicated to providing innovative solutions for every stage of a woman's life, from puberty to menopause. Effik maintains a strong commercial presence in France, Italy, Spain, and other European territories.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Effik Fertilité.